Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine
- PMID: 9466779
- PMCID: PMC104580
- DOI: 10.1128/JCM.36.2.569-572.1998
Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine
Abstract
This report describes the detection of mutations in the pol gene of human immunodeficiency virus type 1 associated with resistance to zidovudine, didanosine, and lamivudine by genotyping by an oligonucleotide ligation assay specific codons in the pol gene amplified by PCR. Our studies demonstrate the sensitivity, simplicity, and specificity of this genotyping system.
Figures
Similar articles
-
Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.J Clin Microbiol. 1995 Feb;33(2):342-7. doi: 10.1128/jcm.33.2.342-347.1995. J Clin Microbiol. 1995. PMID: 7714190 Free PMC article.
-
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.J Infect Dis. 1994 Apr;169(4):722-9. doi: 10.1093/infdis/169.4.722. J Infect Dis. 1994. PMID: 8133086 Clinical Trial.
-
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating Committee.Lancet. 1997 Oct 4;350(9083):983-90. doi: 10.1016/s0140-6736(97)03380-1. Lancet. 1997. PMID: 9329513 Clinical Trial.
-
Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.J Infect Dis. 1995 May;171(5):1152-8. doi: 10.1093/infdis/171.5.1152. J Infect Dis. 1995. PMID: 7751690 Clinical Trial.
-
Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.J Infect Dis. 2001 Sep 15;184(6):781-4. doi: 10.1086/323088. Epub 2001 Aug 7. J Infect Dis. 2001. PMID: 11517441 Clinical Trial.
Cited by
-
Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.Clin Infect Dis. 2010 May 15;50(10):1405-14. doi: 10.1086/652151. Clin Infect Dis. 2010. PMID: 20384494 Free PMC article.
-
Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing.J Clin Microbiol. 2014 Jul;52(7):2320-7. doi: 10.1128/JCM.00306-14. Epub 2014 Apr 16. J Clin Microbiol. 2014. PMID: 24740080 Free PMC article.
-
Oligonucleotide ligation assay for detection of mutations associated with reverse transcriptase and protease inhibitor resistance in non-B subtypes and recombinant forms of human immunodeficiency virus type 1.J Clin Microbiol. 2005 Oct;43(10):5301-4. doi: 10.1128/JCM.43.10.5301-5304.2005. J Clin Microbiol. 2005. PMID: 16208003 Free PMC article.
-
Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants.J Clin Microbiol. 2005 Nov;43(11):5696-704. doi: 10.1128/JCM.43.11.5696-5704.2005. J Clin Microbiol. 2005. PMID: 16272507 Free PMC article.
-
Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy.J Virol. 2003 May;77(10):5721-30. doi: 10.1128/jvi.77.10.5721-5730.2003. J Virol. 2003. PMID: 12719565 Free PMC article.
References
-
- Boucher C A B, Keulen W, van Bommel T, Nijuis M, de Jong D, de Jong M D, Schipper P, Back N K T. Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay. Antimicrob Agents Chemother. 1996;40:2404–2409. - PMC - PubMed
-
- Folks T M, Powell D, Lightfoote M, Koenig S, Fauci A S, Benn S, Rabson A, Daugherty D, Gendelman H E, Hoggan M D, et al. Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med. 1986;164:280–290. - PMC - PubMed
-
- Japour A J, Mayers D L, Johnson V A, Kuritzkes D R, Beckett L A, Arduino J M, Lane J, Black R J, Reichelderfer P S, D’Aquila R T, Crumpacker C S the RV-43 Study Group; the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. Antimicrob Agents Chemother. 1993;37:1095–1101. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical